Literature DB >> 31170503

Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats.

Yingyue Tang1, Jingyi Zhang1, Jing Li1, Xiaohong Lei1, Dongke Xu2, Yang Wang3, Chunmin Li1, Xiaobo Li4, Yimin Mao5.   

Abstract

BACKGROUND: Bile acids (BAs) participate in lipid absorption and serve as metabolic regulatory factors in gut-liver communication. To date, there are no studies on the systemic patterns of BAs in the serum, liver, and gut in the same non-alcoholic fatty liver disease (NAFLD) model.
METHODS: A targeted metabolomics approach and 16S rRNA sequencing were used to identify the profile of BAs and connection between BAs and microbiota. The role and mechanism of altered BAs on hepatic steatosis were investigated.
FINDINGS: In the liver, the composition of taurocholic acid (TCA) was increased, but taurohyodeoxycholic acid (THDCA) and ursodeoxycholic acid (UDCA) were decreased. In the gut, the deconjugated form of TCA (cholic acid (CA)) was increased, while the deconjugated forms of THDCA (α-hyodeoxycholic acid (HDCA)) and ω-muricholic acid (ωMCA) were decreased. In the serum, the composition of TCA was increased, while both HDCA and THDCA were decreased. THDCA induced the gene expression of apolipoprotein, bile secretion-related proteins, and cytochrome P450 family but suppressed inflammatory response genes expression in steatotic hepatocytes by RNAseq analysis. THDCA ameliorated neutral lipid accumulation and improved insulin sensitivity in primary rat hepatocytes. The decreased HDCA level correlated with the level of Bacteroidetes, while the level of CA correlated with the levels of Firmicutes and Verrucomicrobia but correlated inversely with Bacteroidetes.
CONCLUSION: BAs profiles in the serum, liver and caecal content were altered in a rat NAFLD model, which may affect hepatic lipid accumulation and correlate with gut dysbiosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bile acid; Gut microbiota; Non-alcoholic fatty liver disease; TCA; THDCA

Year:  2019        PMID: 31170503     DOI: 10.1016/j.bbalip.2019.05.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  11 in total

Review 1.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

2.  Egr1 confers protection against acetaminophen‑induced hepatotoxicity via transcriptional upregulating of Acaa2.

Authors:  Xiaohong Lei; Qingling Xu; Chunmin Li; Baolin Niu; Yanan Ming; Jing Li; Yingyue Tang; Xiaoyun Li; Jieting Tang; Jing Wu; Yi Ju; Lvfeng Yao; Bin Wang; Qi Miao; Wei Zhong; Yang Zhi; Lirong Xu; Chaojun Li; Xiaobo Li; Yimin Mao
Journal:  Int J Biol Sci       Date:  2022-05-29       Impact factor: 10.750

3.  Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study.

Authors:  Yarong Yang; Zexin Huang; Zhao Yang; Ying Qi; Hui Shi; Yifei Zhou; Fangyu Wang; Miaofang Yang
Journal:  PeerJ       Date:  2021-05-03       Impact factor: 2.984

4.  Supplemental Clostridium butyricum Modulates Lipid Metabolism Through Shaping Gut Microbiota and Bile Acid Profile of Aged Laying Hens.

Authors:  Wei-Wei Wang; Jing Wang; Hai-Jun Zhang; Shu-Geng Wu; Guang-Hai Qi
Journal:  Front Microbiol       Date:  2020-04-15       Impact factor: 5.640

5.  Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.

Authors:  Songsong Wang; Feiya Sheng; Liang Zou; Jianbo Xiao; Peng Li
Journal:  J Adv Res       Date:  2021-06-08       Impact factor: 10.479

6.  Pediococcus acidilactici FZU106 alleviates high-fat diet-induced lipid metabolism disorder in association with the modulation of intestinal microbiota in hyperlipidemic rats.

Authors:  Qing Zhang; Wei-Ling Guo; Gui-Mei Chen; Min Qian; Jin-Zhi Han; Xu-Cong Lv; Li-Jiao Chen; Ping-Fan Rao; Lian-Zhong Ai; Li Ni
Journal:  Curr Res Food Sci       Date:  2022-04-27

7.  Multi-Omics Reveals Inhibitory Effect of Baicalein on Non-Alcoholic Fatty Liver Disease in Mice.

Authors:  Ping Li; Jianran Hu; Hongmei Zhao; Jing Feng; Baofeng Chai
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

Review 8.  Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding-A Review of Rodent Models.

Authors:  Saioa Gómez-Zorita; Leixuri Aguirre; Iñaki Milton-Laskibar; Alfredo Fernández-Quintela; Jenifer Trepiana; Naroa Kajarabille; Andrea Mosqueda-Solís; Marcela González; María P Portillo
Journal:  Nutrients       Date:  2019-09-09       Impact factor: 5.717

9.  Untargeted serum metabolites profiling in high-fat diet mice supplemented with enhanced palm tocotrienol-rich fraction using UHPLC-MS.

Authors:  Danial Efendy Goon; Sharaniza Ab-Rahim; Amir Hakimi Mohd Sakri; Musalmah Mazlan; Jen Kit Tan; Mardiana Abdul Aziz; Norizal Mohd Noor; Effendi Ibrahim; Siti Hamimah Sheikh Abdul Kadir
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379

10.  Activation of the gut microbiota-kynurenine-liver axis contributes to the development of nonalcoholic hepatic steatosis in nondiabetic adults.

Authors:  Guoyuan Sui; Lianqun Jia; Dongmei Quan; Na Zhao; Guanlin Yang
Journal:  Aging (Albany NY)       Date:  2021-09-02       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.